1,077
Views
30
CrossRef citations to date
0
Altmetric
Review

A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators

, , , &
Pages 243-251 | Received 02 Jul 2016, Accepted 19 Jan 2017, Published online: 01 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mafalda M. Dias. (2018) Pharmacotherapy for Social Anxiety Disorder. Issues in Mental Health Nursing 39:12, pages 1047-1048.
Read now

Articles from other publishers (29)

Wenqiang Li, Rui Chen, Laipeng Feng, Xinglun Dang, Jiewei Liu, Tengfei Chen, Jinfeng Yang, Xi Su, Luxian Lv, Tao Li, Zhijun Zhang & Xiong-Jian Luo. (2023) Genome-wide meta-analysis, functional genomics and integrative analyses implicate new risk genes and therapeutic targets for anxiety disorders. Nature Human Behaviour.
Crossref
Max William Loomes & Simon Rosenbaum. 2023. Combining Exercise and Psychotherapy to Treat Mental Health. Combining Exercise and Psychotherapy to Treat Mental Health 1 21 .
David M. Erceg-Hurn, Bruce N.C. Campbell & Peter M. McEvoy. (2023) What explains the failure to identify replicable moderators of symptom change in social anxiety disorder?. Journal of Anxiety Disorders 94, pages 102676.
Crossref
Leydianne Leite de Siqueira Patriota, Bárbara Raíssa Ferreira de Lima, Amanda de Oliveira Marinho, Jainaldo Alves da Costa, Luana Cassandra Breitenbach Barroso Coelho, Patrícia Maria Guedes Paiva, Michelle Melgarejo da Rosa & Thiago Henrique Napoleão. (2023) The anxiolytic-like activity of water-soluble Moringa oleifera Lam. lectin is mediated via serotoninergic, noradrenergic, and dopaminergic neurotransmission. Brain Disorders 9, pages 100066.
Crossref
Preeti SinghNarendra Nath Samantaray. (2021) Brief Cognitive Behavioral Group Therapy and Verbal-Exposure-Augmented Cognitive Behavioral Therapy for Social Anxiety Disorder in University Students: A Randomized Controlled Feasibility Trial. Indian Journal of Psychological Medicine 44:6, pages 552-557.
Crossref
Carlos Murillo, Tat-Thang Vo, Stijn Vansteelandt, Lauren E. Harrison, Barbara Cagnie, Iris Coppieters, Marjolein Chys, Inge Timmers & Mira Meeus. (2022) How do psychologically based interventions for chronic musculoskeletal pain work? A systematic review and meta-analysis of specific moderators and mediators of treatment. Clinical Psychology Review 94, pages 102160.
Crossref
Falk Leichsenring, Christiane Steinert, Sven Rabung & John P.A. Ioannidis. (2022) The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta‐analytic evaluation of recent meta‐analyses. World Psychiatry 21:1, pages 133-145.
Crossref
Boadie Waid Dunlop & Carolina Medeiros Da Frota Ribeiro. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 305 359 .
Amir Garakani, James W. Murrough, Rafael C. Freire, Robyn P. Thom, Kaitlyn Larkin, Frank D. Buono & Dan V. Iosifescu. (2021) Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. FOCUS 19:2, pages 222-242.
Crossref
Daniel Gromer, Dominik P. Kiser & Paul Pauli. (2021) Thigmotaxis in a virtual human open field test. Scientific Reports 11:1.
Crossref
Brenda WJH Penninx, Daniel S Pine, Emily A Holmes & Andreas Reif. (2021) Anxiety disorders. The Lancet 397:10277, pages 914-927.
Crossref
Qiaoyu Sun, Lu Cheng, Xin Zhang, Zufang Wu & Peifang Weng. (2021) The interaction between tea polyphenols and host intestinal microorganisms: an effective way to prevent psychiatric disorders. Food & Function 12:3, pages 952-962.
Crossref
Keming Gao & Jian Zhang. 2021. The Neuroscience of Depression. The Neuroscience of Depression 415 424 .
Amir Garakani, James W. Murrough, Rafael C. Freire, Robyn P. Thom, Kaitlyn Larkin, Frank D. Buono & Dan V. Iosifescu. (2020) Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers in Psychiatry 11.
Crossref
Taryn Williams, Michael McCaul, Guido Schwarzer, Andrea Cipriani, Dan J Stein & Jonathan Ipser. (2020) Pharmacological treatments for social anxiety disorder in adults: a systematic review and network meta-analysis. Acta Neuropsychiatrica 32:4, pages 169-176.
Crossref
Naama Rozen & Idan M. Aderka. (2020) Do depressive symptoms affect the outcome of treatments for SAD? A meta analysis of randomized controlled trials. Clinical Psychology Review 80, pages 101874.
Crossref
Xinyuan Li, Yanbo Hou, Yingying Su, Hongping Liu, Beilin Zhang & Shaokuan Fang. (2020) Efficacy and tolerability of paroxetine in adults with social anxiety disorder. Medicine 99:14, pages e19573.
Crossref
Carmem Beatriz Neufeld, Priscila C. Palma, Kátia A.S. Caetano, Priscila G. Brust-Renck, Joshua Curtiss & Stefan G. Hofmann. (2020) A randomized clinical trial of group and individual Cognitive-Behavioral Therapy approaches for Social Anxiety Disorder. International Journal of Clinical and Health Psychology 20:1, pages 29-37.
Crossref
Boadie Waid Dunlop & Carolina Medeiros Da Frota Ribeiro. 2019. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 56 .
Lichen Ma, Anne-Wil Kruijt, Sofia Nöjd, Elin Zetterlund, Gerhard Andersson & Per Carlbring. (2019) Attentional Bias Modification in Virtual Reality – A VR-Based Dot-Probe Task With 2D and 3D Stimuli. Frontiers in Psychology 10.
Crossref
Falk Leichsenring, Christiane Steinert & John P.A. Ioannidis. (2019) Toward a paradigm shift in treatment and research of mental disorders. Psychological Medicine 49:13, pages 2111-2117.
Crossref
Aidan G. Cashin, Hopin Lee, Sarah E. Lamb, Sally Hopewell, Gemma Mansell, Christopher M. Williams, Steven J. Kamper, Nicholas Henschke & James H. McAuley. (2019) An overview of systematic reviews found suboptimal reporting and methodological limitations of mediation studies investigating causal mechanisms. Journal of Clinical Epidemiology 111, pages 60-68.e1.
Crossref
Heide Klumpp & Jacklynn M. Fitzgerald. (2018) Neuroimaging Predictors and Mechanisms of Treatment Response in Social Anxiety Disorder: an Overview of the Amygdala. Current Psychiatry Reports 20:10.
Crossref
Kátia A. S. Caetano, Barbara Depreeuw, Inka Papenfuss, Joshua Curtiss, Robbert J. Langwerden, Stefan G. Hofmann & Carmem B. Neufeld. (2018) Trial-Based Cognitive Therapy: Efficacy of a New CBT Approach for Treating Social Anxiety Disorder with Comorbid Depression. International Journal of Cognitive Therapy 11:3, pages 325-342.
Crossref
Xue Liu, Xinyuan Li, Congxiao Zhang, Mingze Sun, Ziqian Sun, Yanan Xu & Xiujuan Tian. (2018) Efficacy and tolerability of fluvoxamine in adults with social anxiety disorder. Medicine 97:28, pages e11547.
Crossref
Ymkje Anna Vries, Annelieke M. Roest, Johannes G. M. Burgerhof & Peter Jonge. (2018) Initial severity and antidepressant efficacy for anxiety disorders, obsessive‐compulsive disorder, and posttraumatic stress disorder: An individual patient data meta‐analysis. Depression and Anxiety 35:6, pages 515-522.
Crossref
. 2018. The Immune System and Mental Health. The Immune System and Mental Health 555 664 .
Taryn Williams, Coenie J Hattingh, Catherine M Kariuki, Sean A Tromp, Anton J van Balkom, Jonathan C Ipser & Dan J Stein. (2017) Pharmacotherapy for social anxiety disorder (SAnD). Cochrane Database of Systematic Reviews 2019:1.
Crossref
Falk Leichsenring & Frank Leweke. (2017) Social Anxiety Disorder. New England Journal of Medicine 376:23, pages 2255-2264.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.